| Application no. and date | 16860952.7 (espacenet) (Federated) (European Patent Register), 20161028 | | Patent/reg. no. and date | DK/EP 3368071, 20220126 | | Publication date | 20180905 | | Priority no. and date | US 201562248255 P, 20151029 | | EP pub. no. and date |
EP 3368071 20180905 | | Effective date | | | Applicant/owner | ReVance Therapeutics, Inc., 7555 Gateway Blvd.
Newark, CA 94560, US | | Applicant ref. no. | V441021DK00 | | Inventor | RUEGG, Curtis L., 826 Shepard Way
Redwood City, California 94062, US,
WAUGH, Jacob M., 555 Bryant Street
817
Palo Alto, California 94301, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/08 (2006.01) , A61K 8/64 (2006.01) , A61M 5/178 (2006.01) , A61P 1/00 (2006.01) , A61P 17/02 (2006.01) , A61P 17/10 (2006.01) , A61P 25/00 (2006.01) , A61P 37/00 (2006.01) , A61Q 19/08 (2006.01) | | Title | Injicerbare botulinumtoksinformuleringer og fremgangsmåder til anvendelse deraf med langvarig terapeutisk eller kosmetisk virkning | | Int. application no. | US2016059492 | | Int. publication no. | WO2017075468 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
